نتایج جستجو برای: triple negative breast cancers

تعداد نتایج: 859949  

Journal: :Hacettepe University Journal of the Faculty of Pharmacy 2023

Breast cancer has remained a serious health concern globally for women despite the healthcare advances which have enabled early diagnosis and treatment. Due to its metastatic ability development of resistance chemotherapies, triple-negative breast is an extremely challenging subtype treat. Targeted optimized therapy imperative as these tumors higher recurrence rates than other types cancers. Th...

2013
Jessica Falleti Gino Coletti Ettore Rispoli Francesca Scarabeo Mariarosaria Cervasio Luigi Tornillo Guido Pettinato Luigi Insabato

Acinic cell carcinoma is a rare breast tumour belonging to salivary gland-like tumours of the breast. They are "triple-negative" breast cancers even if their biological behaviour seems to be more favourable. Herein we present an acinic cell carcinoma arising on a background of typical and atypical microglandular adenosis in a 58-year-old woman, along with a review of the literature.

2013
Graham M Poage Zachary C Hartman Powel H Brown

*Correspondence to: Powel H Brown, Email: [email protected] Submitted: 06/20/13; Accepted: 06/24/13 http://dx.doi.org/10.4161/cc.25871 Comment on: Hartman ZC, et al. Cancer Res 2013; 73:3470-80; PMID:23633491; http://dx.doi.org/10.1158/0008-5472.CAN-12-4524-T Breast cancer is second only to nonmelanoma skin cancers as the most prevalent and lethal malignancy among women worldwide. Upon dia...

2011
Yoon Jung Choi Min Hyun Seong Seon Hyeong Choi Shin Ho Kook Hyon Joo Kwag Yong Lai Park Chan Heun Park

PURPOSE Triple receptor-negative (TRN) breast cancer is associated with high risk of recurrence and poor prognosis. The present study assessed the clinicopathologic characteristics and ultrasound (US) features of TRN breast cancers. METHODS Pathological and biological data were reviewed for 558 breast cancer patients treated at Kangbuk Samsung Hospital, between January 2003 and December 2009....

2009
Carmelo Bengala

Triple-negative breast cancer (TNBC) has been recently recognized as an important subgroup of breast cancer with a distinct outcome and therapeutic approach compared with other breast cancer subgroups. Because TNBC is defined by the absence of a target (either hormone receptors or HER-2), conventional cytotoxic therapy is still the mainstay of treatment. This report focuses on the current state...

2015
Markus K Muellner Barbara Mair Yasir Ibrahim Claudia Kerzendorfer Hannelore Lechtermann Claudia Trefzer Freya Klepsch André C Müller Ernestine Leitner Sabine Macho-Maschler Giulio Superti-Furga Keiryn L Bennett José Baselga Uwe Rix Stefan Kubicek Jacques Colinge Violeta Serra Sebastian M B Nijman

Some mutations in cancer cells can be exploited for therapeutic intervention. However, for many cancer subtypes, including triple-negative breast cancer (TNBC), no frequently recurring aberrations could be identified to make such an approach clinically feasible. Characterized by a highly heterogeneous mutational landscape with few common features, many TNBCs cluster together based on their 'bas...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Mark Jesus M Magbanua Lisa A Carey Amy DeLuca Jimmy Hwang Janet H Scott Mothaffar F Rimawi Erica L Mayer P Kelly Marcom Minetta C Liu Francisco J Esteva John W Park Hope S Rugo

PURPOSE Recent developments in rare-cell technology have led to improved blood-based assays that allow for the reliable detection, enumeration, and more recently, genomic profiling of circulating tumor cells (CTC). We evaluated two different approaches for enumeration of CTCs in a prospective therapeutic study of patients with metastatic triple-negative breast cancer (TNBC). EXPERIMENTAL DESI...

Journal: :The breast journal 2013
Janice S Sung Maxine S Jochelson Sandra Brennan Sandra Joo Yong H Wen Chaya Moskowitz Junting Zheng D David Dershaw Elizabeth A Morris

Triple-negative (TN) breast cancers, which are associated with a more aggressive clinical course and poorer prognosis, often present with benign imaging features on mammography and ultrasound. The purpose of this study was to compare the magnetic resonance imaging features of TN breast cancers with estrogen (ER) and progesterone (PR) positive, human epidermal growth factor receptor (HER2) negat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید